Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals
Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals
复制标题
DOI:
10.1016/j.immuni.2017.05.006
复制
发表时间:
2017-06-20
期刊:
影响因子:
32.4
通讯作者:
Zhou, Xi
中科院分区:
文献类型:
--
作者:
Qiu, Yang;Xu, Yanpeng;Zhou, Xi
RNA interference (RNAi) functions as a potent antiviral immunity in plants and invertebrates; however, whether RNAi plays antiviral roles in mammals remains unclear. Here, using human enterovirus 71 (HEV71) as a model, we showed HEV71 3A protein as an authentic viral suppressor of RNAi during viral infection. When the 3A-mediated RNAi suppression was impaired, the mutant HEV71 readily triggered the production of abundant HEV71-derived small RNAs with canonical siRNA properties in cells and mice. These virus-derived siRNAs were produced from viral dsRNA replicative intermediates in a Dicer-dependent manner and loaded into AGO, and they were fully active in degrading cognate viral RNAs. Recombinant HEV71 deficient in 3A-mediated RNAi suppression was significantly restricted in human somatic cells and mice, whereas Dicer deficiency rescued HEV71 infection independently of type I interferon response. Thus, RNAi can function as an antiviral immunity, which is induced and suppressed by a human virus, in mammals.